131I-MIBG - Fujifilm RI PharmaAlternative Names: 131I-MIBG - Fujifilm Pharma; I-131 3-iodobenzylguanidine
Latest Information Update: 02 Feb 2017
At a glance
- Originator FUJIFILM RI Pharma
- Class Antineoplastics; Iodobenzenes; Radiopharmaceuticals; Small molecules
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Neuroblastoma
Most Recent Events
- 30 Nov 2016 Fujifilm Pharma plans to initiate a clinical trial in Neuroblastoma in Japan (UMIN000025045)
- 29 Nov 2016 Preclinical trials in Neuroblastoma in Japan (unspecified route) (UMIN000025045)